Table 1 |
||||
|
Adherence Input Values |
||||
|
Part A: Adherence Rates by Medication |
||||
|
|
||||
|
Medications |
Full |
Partial |
Non |
|
|
|
||||
|
Olanzapine |
23% |
43% |
34% |
|
|
Risperidone |
21% |
39% |
40% |
Ahn et al., 2007 [62]; Ascher-Svanum et al., 2009 [22] |
|
Quetiapine |
19% |
35% |
46% |
|
|
Ziprasidone |
19% |
35% |
46% |
Assumed equal to quetiapine |
|
Aripiprazole |
19% |
35% |
46% |
Assumed equal to quetiapine |
|
|
||||
|
Part B: Adherence Rate by Level in Cycle Following Relapse |
||||
|
|
||||
|
Adherence Level Prior to Relapse |
Full Adherence After Relapse |
Partial Adherence After Relapse |
Non-Adherence After Relapse |
|
|
|
||||
|
Full adherence |
92.03% |
1.45% |
6.52% |
|
|
Partial adherence |
75.00% |
12.50% |
12.50% |
Ascher-Svanum et al., 2009 [22] |
|
Nonadherence |
38.70% |
9.70% |
51.60% |
|
|
|
||||
|
Furiak et al. Cost Effectiveness and Resource Allocation 2009 7:4 doi:10.1186/1478-7547-7-4 |
||||